2 hours ago
1
Worawith Ounpeng/iStock via Getty Images
LB Pharmaceuticals (LBRX) climbed ~26% on Thursday as the New York-based biopharma, focused on developing drugs for neurological conditions such as schizophrenia, opened for trading after raising $285M from its IPO.
Late Wednesday, the company priced the offering of roughly 19M
English (US) ·